A NEW ERA OF IMMUNE BIOMARKERS
Compelling insights powered by our analytical engine ImmunoINSIGHTS™
The leading antibody biomarker discovery platform to advance precision medicine
Our Technology & Science
ImmunoINSIGHTS™ the analytical engine adding insights to your clinical data
Oncimmune has developed the most advanced and comprehensive analytical platform for the discovery of Antibody / Autoantibody Biomarker Signatures. ImmunoINSIGHTS™, the best-in-class biomarker discovery engine, provides access to the B cell repertoire and a pivotal class of biomarkers.
With one of the world’s largest antigen libraries covering 9000+ human antigens and multi-species variants, we profile antibodies from various biologic samples in very low volume (50 µl). Developed and curated by immunologists and a team of bioinformaticians, we offer high content biological insights and analytics powered by proprietary machine learning algorithms, models and deep knowledge mining solutions. Our platform uses Luminex xMAP® – the world’s most used multiplexing technology.
At Oncimmune, our mission is to develop innovative technologies and solutions to improve the understanding of the immune system leading to more effective, targeted and safer treatments and better diagnosis. Our scientists work hand-in-hand with our clients to discover relevant and insightful biomarkers.
Robust & Reproducible
Bead-based multiplexed immunoassay Luminex xMAP® Technology
Largest Antigen Library
9000+ human antigens & multi-species variants available for interrogation
Minimal Sample Volume
<50 µl per sample
(serum, plasma and others)
High-Throughput
Large numbers of samples through automated robotic workflows
Rapid & Reliable
Tailored to your projects
Panel Customization
Tailored to specific studies
Collaborative
Ongoing partnering and communications
Advanced Bioinformatics & Data Science
Advanced data insights, analytics and the flexibility of multiomics data integration
Broad Expertise in Immunology
Our proprietary platform, ImmunoINSIGHTS™ can be applied across different therapeutic and disease areas for a wide range of biomarker applications
